TET1 and basal cell carcinoma: Specifically, TET-1 could be proposed in the case of cutaneous diseases affecting more superficial strata, such as acute inflammatory dermatoses, and ET could be proposed to treat deeper and more serious conditions, such as basal cell carcinoma and melanoma.